CRO News
Sygnature Discovery Unveils £1M Upgrade to High-Throughput Chemistry Platform
Sygnature Discovery, an integrated drug discovery contract research organisation (CRO), has announced the completion of a £1 million enhancement to its high-throughput chemistry (HTC) capabilities and laboratory infrastructure. The investment has resulted in a doubling of synthesis and purification capacity,
24 July 2025
